APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Piroxicam Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Piroxicam Capsules Market Outlook and Growth Opportunities 2026

Report ID 174026060427 December 2025195 pages

Choose your research edition.

Industry ResearchPiroxicam Capsules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Piroxicam Capsules Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Piroxicam Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Piroxicam Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Piroxicam Capsules Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Piroxicam Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Piroxicam Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Piroxicam Capsules market include Chongqing Kerui Pharmaceutical, Pfizer, Guangzhou Ouhua Pharmaceutica, Baiyunshan, Guangdong Zhongsheng Pharmaceutical, Guangdong Xinfeng Pharmaceutical, Guangdong Pidi Pharmaceutical, Teva Pharmaceuticals USA and SK Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Piroxicam Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Piroxicam Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Piroxicam Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Piroxicam Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Piroxicam Capsules Segment by Company

Chongqing Kerui Pharmaceutical

Pfizer

Guangzhou Ouhua Pharmaceutica

Baiyunshan

Guangdong Zhongsheng Pharmaceutical

Guangdong Xinfeng Pharmaceutical

Guangdong Pidi Pharmaceutical

Teva Pharmaceuticals USA

SK Chemical

Nouvasant Group

Elikem Pharmaceuticals

DevLife

AdvaCare Pharma

Piroxicam Capsules Segment by Type

Regular Release

Modified Release

Piroxicam Capsules Segment by Application

Hospital

Clinic

Pharmacy

Piroxicam Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Piroxicam Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Piroxicam Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Piroxicam Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Piroxicam Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Piroxicam Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Piroxicam Capsules industry.

Chapter 3: Detailed analysis of Piroxicam Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Piroxicam Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Piroxicam Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Piroxicam Capsules Industry Trends Table 2. Piroxicam Capsules Industry Drivers Table 3. Piroxicam Capsules Industry Opportunities and Challenges Table 4. Piroxicam Capsules Industry Restraints Table 5. Global Piroxicam Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Piroxicam Capsules Revenue Share by Company (2021-2026) Table 7. Global Piroxicam Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Piroxicam Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Piroxicam Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Piroxicam Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Piroxicam Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Piroxicam Capsules Company, Product Type & Application Table 13. Global Piroxicam Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Piroxicam Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Regular Release Table 18. Significant Companies of Modified Release Table 19. Global Piroxicam Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Piroxicam Capsules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Piroxicam Capsules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Piroxicam Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Piroxicam Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Piroxicam Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Piroxicam Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Piroxicam Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Piroxicam Capsules Sales Value Share by Type (2021-2026) Table 28. Global Piroxicam Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Pharmacy Table 32. Global Piroxicam Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Piroxicam Capsules Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Piroxicam Capsules Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Piroxicam Capsules Sales Volume Share by Application (2021-2026) Table 36. Global Piroxicam Capsules Sales Volume Share by Application (2027-2032) Table 37. Global Piroxicam Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Piroxicam Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Piroxicam Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Piroxicam Capsules Sales Value Share by Application (2021-2026) Table 41. Global Piroxicam Capsules Sales Value Share by Application (2027-2032) Table 42. Global Piroxicam Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Piroxicam Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Piroxicam Capsules Sales Market Share by Region (2021-2026) Table 45. Global Piroxicam Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Piroxicam Capsules Sales Market Share by Region (2027-2032) Table 47. Global Piroxicam Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Piroxicam Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Piroxicam Capsules Sales Value Share by Region (2021-2026) Table 50. Global Piroxicam Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Piroxicam Capsules Sales Value Share by Region (2027-2032) Table 52. Global Piroxicam Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Piroxicam Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Piroxicam Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Piroxicam Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Piroxicam Capsules Sales by Country (2021-2026) & (K Units) Table 57. Global Piroxicam Capsules Sales Market Share by Country (2021-2026) Table 58. Global Piroxicam Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Piroxicam Capsules Sales Market Share by Country (2027-2032) Table 60. Global Piroxicam Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Piroxicam Capsules Sales Value Market Share by Country (2021-2026) Table 62. Global Piroxicam Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Piroxicam Capsules Sales Value Market Share by Country (2027-2032) Table 64. Chongqing Kerui Pharmaceutical Company Information Table 65. Chongqing Kerui Pharmaceutical Business Overview Table 66. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio Table 68. Chongqing Kerui Pharmaceutical Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Pfizer Piroxicam Capsules Product Portfolio Table 73. Pfizer Recent Development Table 74. Guangzhou Ouhua Pharmaceutica Company Information Table 75. Guangzhou Ouhua Pharmaceutica Business Overview Table 76. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio Table 78. Guangzhou Ouhua Pharmaceutica Recent Development Table 79. Baiyunshan Company Information Table 80. Baiyunshan Business Overview Table 81. Baiyunshan Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Baiyunshan Piroxicam Capsules Product Portfolio Table 83. Baiyunshan Recent Development Table 84. Guangdong Zhongsheng Pharmaceutical Company Information Table 85. Guangdong Zhongsheng Pharmaceutical Business Overview Table 86. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio Table 88. Guangdong Zhongsheng Pharmaceutical Recent Development Table 89. Guangdong Xinfeng Pharmaceutical Company Information Table 90. Guangdong Xinfeng Pharmaceutical Business Overview Table 91. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio Table 93. Guangdong Xinfeng Pharmaceutical Recent Development Table 94. Guangdong Pidi Pharmaceutical Company Information Table 95. Guangdong Pidi Pharmaceutical Business Overview Table 96. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio Table 98. Guangdong Pidi Pharmaceutical Recent Development Table 99. Teva Pharmaceuticals USA Company Information Table 100. Teva Pharmaceuticals USA Business Overview Table 101. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio Table 103. Teva Pharmaceuticals USA Recent Development Table 104. SK Chemical Company Information Table 105. SK Chemical Business Overview Table 106. SK Chemical Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. SK Chemical Piroxicam Capsules Product Portfolio Table 108. SK Chemical Recent Development Table 109. Nouvasant Group Company Information Table 110. Nouvasant Group Business Overview Table 111. Nouvasant Group Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Nouvasant Group Piroxicam Capsules Product Portfolio Table 113. Nouvasant Group Recent Development Table 114. Elikem Pharmaceuticals Company Information Table 115. Elikem Pharmaceuticals Business Overview Table 116. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio Table 118. Elikem Pharmaceuticals Recent Development Table 119. DevLife Company Information Table 120. DevLife Business Overview Table 121. DevLife Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. DevLife Piroxicam Capsules Product Portfolio Table 123. DevLife Recent Development Table 124. AdvaCare Pharma Company Information Table 125. AdvaCare Pharma Business Overview Table 126. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. AdvaCare Pharma Piroxicam Capsules Product Portfolio Table 128. AdvaCare Pharma Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Piroxicam Capsules Distributors List Table 132. Piroxicam Capsules Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Piroxicam Capsules Product Image Figure 2. Global Piroxicam Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Piroxicam Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Piroxicam Capsules Sales (2021-2032) & (K Units) Figure 5. Global Piroxicam Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Piroxicam Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Regular Release Image Figure 10. Modified Release Image Figure 11. Global Piroxicam Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Piroxicam Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Piroxicam Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Piroxicam Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Piroxicam Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Piroxicam Capsules Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Pharmacy Image Figure 20. Global Piroxicam Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Piroxicam Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Piroxicam Capsules Sales Volume Share by Application (2021-2032) Figure 23. Global Piroxicam Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Piroxicam Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Piroxicam Capsules Sales Value Share by Application (2021-2032) Figure 26. Global Piroxicam Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Piroxicam Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Piroxicam Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Piroxicam Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Piroxicam Capsules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Piroxicam Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Piroxicam Capsules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Piroxicam Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Piroxicam Capsules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Piroxicam Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Piroxicam Capsules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Piroxicam Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Piroxicam Capsules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Piroxicam Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Piroxicam Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Piroxicam Capsules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Piroxicam Capsules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Release
  • Modified Release
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Chongqing Kerui Pharmaceutical
  • Pfizer
  • Guangzhou Ouhua Pharmaceutica
  • Baiyunshan
  • Guangdong Zhongsheng Pharmaceutical
  • Guangdong Xinfeng Pharmaceutical
  • Guangdong Pidi Pharmaceutical
  • Teva Pharmaceuticals USA
  • SK Chemical
  • Nouvasant Group
  • Elikem Pharmaceuticals
  • DevLife
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Piroxicam Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Piroxicam Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Piroxicam Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Piroxicam Capsules Market Dynamics
  1. 2.1 Piroxicam Capsules Industry Trends
  2. 2.2 Piroxicam Capsules Industry Drivers
  3. 2.3 Piroxicam Capsules Industry Opportunities and Challenges
  4. 2.4 Piroxicam Capsules Industry Restraints
3 Piroxicam Capsules Market by Company
  1. 3.1 Global Piroxicam Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Piroxicam Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Piroxicam Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Piroxicam Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Piroxicam Capsules Company Ranking (2024-2026)
  6. 3.6 Global Piroxicam Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Piroxicam Capsules Company Product Type and Application
  8. 3.8 Global Piroxicam Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Piroxicam Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Piroxicam Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Piroxicam Capsules Market by Type
  1. 4.1 Piroxicam Capsules Type Introduction
  2. 4.1.1 Regular Release
  3. 4.1.2 Modified Release
  4. 4.2 Global Piroxicam Capsules Sales Volume by Type
  5. 4.2.1 Global Piroxicam Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Piroxicam Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Piroxicam Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Piroxicam Capsules Sales Value by Type
  9. 4.3.1 Global Piroxicam Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Piroxicam Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Piroxicam Capsules Sales Value Share by Type (2021-2032)
5 Piroxicam Capsules Market by Application
  1. 5.1 Piroxicam Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Piroxicam Capsules Sales Volume by Application
  6. 5.2.1 Global Piroxicam Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Piroxicam Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Piroxicam Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Piroxicam Capsules Sales Value by Application
  10. 5.3.1 Global Piroxicam Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Piroxicam Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Piroxicam Capsules Sales Value Share by Application (2021-2032)
6 Piroxicam Capsules Regional Sales and Value Analysis
  1. 6.1 Global Piroxicam Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Piroxicam Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Piroxicam Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Piroxicam Capsules Sales by Region (2027-2032)
  5. 6.3 Global Piroxicam Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Piroxicam Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Piroxicam Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Piroxicam Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Piroxicam Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Piroxicam Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Piroxicam Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Piroxicam Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Piroxicam Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Piroxicam Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Piroxicam Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Piroxicam Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Piroxicam Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Piroxicam Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Piroxicam Capsules Sales Value Share by Country, 2025 VS 2032
7 Piroxicam Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Piroxicam Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Piroxicam Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Piroxicam Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Piroxicam Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Piroxicam Capsules Sales by Country (2027-2032)
  6. 7.4 Global Piroxicam Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Piroxicam Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Piroxicam Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Piroxicam Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Piroxicam Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Piroxicam Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Kerui Pharmaceutical
  2. 8.1.1 Chongqing Kerui Pharmaceutical Company Information
  3. 8.1.2 Chongqing Kerui Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio
  6. 8.1.5 Chongqing Kerui Pharmaceutical Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Piroxicam Capsules Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Guangzhou Ouhua Pharmaceutica
  14. 8.3.1 Guangzhou Ouhua Pharmaceutica Company Information
  15. 8.3.2 Guangzhou Ouhua Pharmaceutica Business Overview
  16. 8.3.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio
  18. 8.3.5 Guangzhou Ouhua Pharmaceutica Recent Developments
  19. 8.4 Baiyunshan
  20. 8.4.1 Baiyunshan Company Information
  21. 8.4.2 Baiyunshan Business Overview
  22. 8.4.3 Baiyunshan Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Baiyunshan Piroxicam Capsules Product Portfolio
  24. 8.4.5 Baiyunshan Recent Developments
  25. 8.5 Guangdong Zhongsheng Pharmaceutical
  26. 8.5.1 Guangdong Zhongsheng Pharmaceutical Company Information
  27. 8.5.2 Guangdong Zhongsheng Pharmaceutical Business Overview
  28. 8.5.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio
  30. 8.5.5 Guangdong Zhongsheng Pharmaceutical Recent Developments
  31. 8.6 Guangdong Xinfeng Pharmaceutical
  32. 8.6.1 Guangdong Xinfeng Pharmaceutical Company Information
  33. 8.6.2 Guangdong Xinfeng Pharmaceutical Business Overview
  34. 8.6.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio
  36. 8.6.5 Guangdong Xinfeng Pharmaceutical Recent Developments
  37. 8.7 Guangdong Pidi Pharmaceutical
  38. 8.7.1 Guangdong Pidi Pharmaceutical Company Information
  39. 8.7.2 Guangdong Pidi Pharmaceutical Business Overview
  40. 8.7.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio
  42. 8.7.5 Guangdong Pidi Pharmaceutical Recent Developments
  43. 8.8 Teva Pharmaceuticals USA
  44. 8.8.1 Teva Pharmaceuticals USA Company Information
  45. 8.8.2 Teva Pharmaceuticals USA Business Overview
  46. 8.8.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals USA Recent Developments
  49. 8.9 SK Chemical
  50. 8.9.1 SK Chemical Company Information
  51. 8.9.2 SK Chemical Business Overview
  52. 8.9.3 SK Chemical Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 SK Chemical Piroxicam Capsules Product Portfolio
  54. 8.9.5 SK Chemical Recent Developments
  55. 8.10 Nouvasant Group
  56. 8.10.1 Nouvasant Group Company Information
  57. 8.10.2 Nouvasant Group Business Overview
  58. 8.10.3 Nouvasant Group Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nouvasant Group Piroxicam Capsules Product Portfolio
  60. 8.10.5 Nouvasant Group Recent Developments
  61. 8.11 Elikem Pharmaceuticals
  62. 8.11.1 Elikem Pharmaceuticals Company Information
  63. 8.11.2 Elikem Pharmaceuticals Business Overview
  64. 8.11.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio
  66. 8.11.5 Elikem Pharmaceuticals Recent Developments
  67. 8.12 DevLife
  68. 8.12.1 DevLife Company Information
  69. 8.12.2 DevLife Business Overview
  70. 8.12.3 DevLife Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 DevLife Piroxicam Capsules Product Portfolio
  72. 8.12.5 DevLife Recent Developments
  73. 8.13 AdvaCare Pharma
  74. 8.13.1 AdvaCare Pharma Company Information
  75. 8.13.2 AdvaCare Pharma Business Overview
  76. 8.13.3 AdvaCare Pharma Piroxicam Capsules Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 AdvaCare Pharma Piroxicam Capsules Product Portfolio
  78. 8.13.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Piroxicam Capsules Value Chain Analysis
  2. 9.1.1 Piroxicam Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Piroxicam Capsules Sales Mode & Process
  6. 9.2 Piroxicam Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Piroxicam Capsules Distributors
  9. 9.2.3 Piroxicam Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst